Some psychiatrists are developing a method for treating Post Traumatic Stress Disorder (PTSD) by using MDMA to suppress flashbacks and acute stress during cognitive behavioral therapy sessions. It has successfully completed Phase II clinical trials and is moving to Phase III. But, if successful, the approach faces an additional barrier--the Controlled Substances Act.
IMAGE BY THE MARINES VIA FLICKR